Criminal Justice Reform and Addiction Treatment Access

Many people in jails and prisons have substance-use treatment needs, and continuity of care during incarceration and reentry remains uneven. Program availability and eligibility differ by facility and jurisdiction.

Some jurisdictions in Virginia, Ohio, and Pennsylvania operate drug courts, diversion programs, or medication treatment in correctional settings. These programs are not uniform, and participation can involve legal and clinical requirements.

This article describes common program models and questions to ask. It does not determine eligibility, predict a court outcome, or provide legal advice.

What Are Drug Courts and How Do They Work?

Drug courts are specialized court programs that offer people facing criminal charges an alternative to traditional prosecution: complete a supervised treatment program instead of going to jail.

Here's how the process typically works:

Eligibility screening: Not everyone qualifies. Most drug courts focus on non-violent offenses and require participants to have a documented substance use disorder. Violent crimes and major trafficking charges usually disqualify someone.

Treatment-centered supervision: Participants enter intensive outpatient or residential treatment programs. They attend regular court check-ins (often weekly at first) where judges review their progress, order drug tests, and adjust requirements based on how they're doing.

Graduated sanctions and rewards: Miss an appointment or test positive? You might face increased supervision or brief jail stays. Meet milestones? Courts reduce check-in frequency, dismiss charges, or expunge records upon graduation.

Duration: Most programs last 12–24 months — long enough for treatment to take root, but structured to keep participants motivated.

The model works because it combines accountability with support. Instead of facing a judge once at sentencing, participants see the same judge regularly, building a relationship that recognizes their progress and holds them accountable when they slip.

Program evaluations vary in design and results. To assess a local drug court, review current eligibility rules, completion measures, medication policies, sanctions, and independently reported outcomes.

How Do Pre-Trial Diversion Programs Expand Treatment Access?

Pre-trial diversion programs intervene even earlier in the criminal justice process — before charges are formally filed or before trial begins. They're designed to keep people with addiction out of jail entirely while connecting them to treatment.

These programs work differently than drug courts:

Earlier intervention: Diversion can happen within days of arrest, preventing even short jail stays that disrupt employment, housing, and family stability.

Charges held or dismissed: Prosecutors agree to pause or drop charges if the person completes treatment and stays out of trouble for a set period (often 6–12 months).

Less court involvement: Participants typically check in with a case manager or probation officer instead of appearing regularly before a judge.

Broader eligibility: Some diversion programs accept people with more serious charges or prior records that would disqualify them from drug court.

In Ohio, diversion availability differs by county and case. Contact local counsel or the relevant court for current information in areas such as Columbus and Cleveland.

Pennsylvania jurisdictions, including Philadelphia and Pittsburgh, may offer programs that connect eligible participants with treatment. Current program administrators can explain whether medication-assisted treatment is supported.

These programs recognize a critical reality: jail doesn't treat addiction. In fact, incarceration often worsens outcomes by disconnecting people from community supports, jobs, and healthcare. Diversion programs break that cycle before it starts.

Is Medication-Assisted Treatment Available in Jails and Prisons?

For decades, most jails and prisons didn't allow medications like Suboxone (buprenorphine) or methadone, even though they're the gold standard for opioid use disorder treatment. People who were stable on MAT before arrest faced forced withdrawal — medically unnecessary, dangerous, and traumatic.

That's changing, though progress remains uneven:

Pregnancy-related care: Pregnant people should receive prompt clinical evaluation and continuity planning. Legal requirements and facility policies are fact-specific; consult qualified counsel or an advocacy organization for legal guidance.

Virginia facilities: Medication availability and admission procedures may differ across facilities, including those serving Richmond, Norfolk, and Roanoke. Verify directly with the facility or current state resources.

Ohio facilities: Some county facilities have medication programs, but availability and transition planning vary. Verify the current program directly.

Pennsylvania facilities: State and county systems may follow different medication policies. Verify current availability with the Department of Corrections or the individual county facility.

Access behind bars matters for two critical reasons:

First, it keeps people alive. Overdose risk spikes in the first two weeks after release, when tolerance has dropped but cravings remain intense. Continuing MAT through incarceration and into the community dramatically reduces that risk.

Second, it improves reentry success. People who stay on MAT during incarceration are more likely to find housing, maintain employment, and avoid re-arrest. Treatment continuity makes all the difference.

Not every facility offers MAT yet, though. If you or someone you care about is facing incarceration while on Suboxone, it's worth asking the facility about their MAT policies before admission. Public defenders and advocacy groups can sometimes intervene to ensure treatment continues.

How Do Post-Release Treatment Programs Prevent Relapse?

The period after release can carry elevated overdose risk, particularly after a loss of opioid tolerance. Discharge planning should include clinical follow-up and access to naloxone where appropriate; call 911 for a suspected overdose.

That's why post-release treatment linkage is critical. Here's how effective programs work:

In-reach before release: Case managers meet with people 30–60 days before their release date to arrange housing, connect them with treatment providers, and ensure they have insurance coverage (often Medicaid) activated on day one.

Medication starts inside: Ideally, people start or continue MAT while still incarcerated. That way, they leave with medication in their system and a prescription in hand, rather than facing a treatment gap.

Same-day or next-day appointments: The best programs schedule people for their first community treatment appointment within 24–72 hours of release. Telehealth options make this easier in rural areas where transportation is a barrier.

Wraparound support: Effective reentry programs don't just treat addiction. They help people navigate probation requirements, find stable housing, access mental health care, and rebuild family relationships.

Grata Health offers telehealth treatment in Virginia, Ohio, and Pennsylvania. Appointment availability, clinical eligibility, insurance activation, and coverage must be confirmed for each person.

Telehealth may help with transportation barriers after release, but it does not guarantee rapid access or a particular outcome.

Getting started with online Suboxone treatment removes common barriers like transportation, childcare, and taking time off work — obstacles that often derail treatment in those critical early weeks of freedom.

What Does the Evidence Say About Treatment vs. Incarceration?

Decades of research show that addiction treatment reduces crime more effectively than incarceration alone — and at a fraction of the cost.

Here are the numbers:

Recidivism: Program results depend on population, design, local conditions, and how re-arrest is measured. Review credible evaluations rather than relying on a universal percentage.

Overdose risk: Medications for opioid use disorder are evidence-based care, but risk remains and individual outcomes cannot be promised.

Cost savings: Incarcerating someone costs taxpayers an average of $35,000 per year. Outpatient MAT costs about $5,000 per year. Even when including case management, drug testing, and counseling, treatment-focused approaches save money.

Employment: Treatment may support stability, but employment depends on many personal, economic, and legal factors.

Child welfare: Treatment participation does not guarantee custody or reunification. Parents should obtain case-specific advice and document compliance with applicable clinical and court requirements.

The shift toward treatment-focused criminal justice reform isn't about being "soft on crime." It's about being smart: investing in what actually works to reduce harm, save lives, and rebuild communities.

How Are Opioid Settlement Funds Supporting These Programs?

Between 2021 and 2025, Virginia, Ohio, and Pennsylvania collectively received more than $2.1 billion from opioid litigation settlements with pharmaceutical companies. Much of that money is being directed toward expanding treatment access in the criminal justice system.

Here's how settlement funds are being used:

Drug courts: Funding and capacity change over time. Consult current state and local budget or court sources for program availability.

Jail-based MAT programs: Funding, staffing, medications, and eligibility vary by facility and budget cycle.

Reentry support: All three states funded pilot programs that provide housing vouchers, transportation assistance, and peer recovery coaching for people transitioning from incarceration to community treatment.

Telehealth infrastructure: Settlement funds supported grants to rural health systems and telehealth providers (like Grata Health) to ensure people in areas with few addiction specialists can access MAT via video visits.

To learn more about how these funds are being used in your state, see our article on opioid settlement funds and treatment access.

What Challenges Remain in Criminal Justice Reform?

Despite progress, significant barriers still limit treatment access in the criminal justice system:

Inconsistent MAT access: While some jails now offer buprenorphine, others still force people to withdraw. There's no federal requirement for universal MAT access in jails or prisons.

Stigma among correctional staff: Some officers and administrators still view MAT as "replacing one drug with another," leading to resistance or policy sabotage even when programs exist on paper.

Funding gaps: Drug courts and diversion programs rely heavily on grants that expire. Without sustained state funding, many programs close when initial money runs out.

Insurance activation delays: People leaving incarceration often face weeks-long delays in activating Medicaid coverage, creating a dangerous treatment gap. Some states have started pre-enrollment programs, but they're not universal.

Limited rural access: Counties with small populations often lack drug courts or specialized diversion programs. Telehealth helps, but internet access and device availability remain barriers.

Probation conflicts with treatment: Some probation officers still mandate abstinence-only programs or prohibit MAT, contradicting medical evidence and putting people at risk.

Advocates are pushing for federal legislation to guarantee MAT access in all correctional facilities, mandate Medicaid activation before release, and tie criminal justice funding to evidence-based treatment standards. Progress is slow but steady.

Does Treatment-Focused Justice Work for Everyone?

Drug courts and diversion programs aren't a perfect fit for every situation. Some people need higher levels of care than outpatient programs provide. Others face charges serious enough that public safety requires incarceration.

Treatment access is an important part of a public-health response, while courts make case-specific decisions under applicable law.

The key is meeting people where they are. That means offering different phases of treatment as people progress, recognizing that relapse is part of recovery, and designing systems that support long-term success rather than punishing setbacks.

If you're navigating the criminal justice system while managing opioid use disorder, ask your clinician, supervising authority, and qualified lawyer how treatment rules apply to your case. A public defender or advocacy organization may be able to provide legal guidance.

And if you're ready to start treatment — whether you're currently incarcerated, recently released, or just worried about legal consequences of seeking help — know that getting treatment is always the right move. Courts, probation officers, and judges increasingly recognize MAT as legitimate medical care, not a legal liability.

Grata Health provides telehealth appointments across Virginia, Ohio, and Pennsylvania. Coverage, cost, availability, and clinical eligibility vary.

Criminal justice reform and addiction treatment access aren't separate issues — they're two sides of the same effort to break cycles of harm and help people rebuild their lives. The evidence is clear, the programs are expanding, and the path forward is treatment, not incarceration.

Get started with online Suboxone treatment today and take the first step toward recovery, no matter where you're starting from.

Grata Health offers same-day telehealth appointments in Virginia, Ohio, and Pennsylvania and accepts most insurance plans. Specific benefits and eligibility vary by plan and individual circumstances.